Effect of Empagliflozin Versus Placebo on Brain Insulin Sensitivity in Patients With Prediabetes
NCT03227484
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
42
Enrollment
OTHER
Sponsor class
Conditions
PreDiabetes
Body Weight
Interventions
DRUG:
Empagliflozin 25mg
DRUG:
Placebo Oral Tablet
Sponsor
University Hospital Tuebingen